139例肺腺鳞癌的预后因素分析(3)
第1页 |
参见附件。
[12] Douillard J,Rosell R, Delena M, et alANITA:Phase III adjuvant vinorelbine(N)and cisplatin(P)versus observation(OBS) in completely resected(stage) nonsmall cell lung cancer(NSCLC)patientsJ Clin Oncol,2005,23(suppl16):S624.
[13] Cooke DT, Nguyen DV, Yang Y, et al Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy Ann Thorac Surg, 2010,90(3):943948.
[14] Bastide K, Ugolin N, Levalois C, et al Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level? Lung Cancer,2010,68(1):19.
[15] Tochigi N, Dacic S, Nikiforova M,et alAdenosquamous carcinoma of the lung:a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population Am J Clin Pathol, 2011,135(5):783789.
[16] Kang SM, Kang HJ, Shin JH,et alIdentical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung Cancer,2007,109(3):581587.
您现在查看是摘要介绍页,详见PDF附件(3296kb)。